Medicare Enrolled

Dr. Alain Alvarez

Rheumatology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6605 HILLWAY CIR STE 101, Naples, FL 34112
2392626550
In practice since 2008 (17 years)
NPI: 1841457496 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alvarez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alvarez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alvarez

Dr. Alain Alvarez is a rheumatology in Naples, FL, with 17 years in practice. Based on federal Medicare data, Dr. Alvarez performed 230,873 Medicare services across 1,464 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alvarez received a total of $33,039 from 53 pharmaceutical and/or device companies across 1184 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alvarez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 6% volume in FL$ $33,039 industry payments

Medicare Practice Summary

Medicare Utilization ↗
230,873
Medicare services
Top 6% in FL for rheumatology
1,464
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,581 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)136,400$4$11
Tocilizumab injection (Actemra)32,120$5$11
Golimumab infusion (Simponi Aria)28,800$11$27
Romosozumab injection (Evenity) for osteoporosis13,230$8$22
Abatacept infusion (Orencia)10,775$34$85
Denosumab injection (Prolia/Xgeva)4,200$18$43
Infliximab infusion (Remicade)1,520$27$75
Office visit, established patient (30-39 min)925$99$281
Steroid injection (triamcinolone)921$1$15
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle828$60$140
Administration of chemotherapy into vein, 1 hour or less443$103$361
New patient office visit (45-59 min)120$122$434
Office visit, established patient (20-29 min)114$67$192
Aspiration and/or injection of fluid large joint using ultrasound guidance107$81$246
Aspiration and/or injection of fluid from medium joint using ultrasound guidance73$74$215
Injection into tendon or ligament64$45$142
Administration of chemotherapy into vein, each additional hour55$22$115
New patient office visit, complex (60-74 min)51$166$547
Ultrasonic guidance for needle placement49$45$158
Office visit, established patient, complex (40-54 min)43$140$380
Injection, methylprednisolone acetate, 20 mg35$4$26
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.8% high complexity
81.6% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$33,039
Total received (2018-2024)
Avg $4,720/year across 7 years
Top 15% in FL for rheumatology
53
Companies
1,184
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,939 (75.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,586 (16.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,515 (7.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,823
2023
$7,226
2022
$5,510
2021
$4,983
2020
$4,190
2019
$3,303
2018
$3,004

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$5,858
Janssen Biotech, Inc.
$5,095
Horizon Therapeutics plc
$2,850
Novartis Pharmaceuticals Corporation
$2,439
GENZYME CORPORATION
$2,420
UCB, Inc.
$1,742
Lilly USA, LLC
$1,551
ABBVIE INC.
$1,231
E.R. Squibb & Sons, L.L.C.
$1,104
AbbVie, Inc.
$1,038
AstraZeneca Pharmaceuticals LP
$889
AbbVie Inc.
$831
PFIZER INC.
$790
Mallinckrodt Hospital Products Inc.
$687
Janssen Scientific Affairs, LLC
$647
GlaxoSmithKline, LLC.
$503
Boehringer Ingelheim Pharmaceuticals, Inc.
$460
Mallinckrodt Enterprises LLC
$313
Genentech, Inc.
$288
Genentech USA, Inc.
$274
Celgene Corporation
$261
Radius Health, Inc.
$227
Fresenius Kabi USA, LLC
$146
Antares Pharma, Inc.
$123
Fidia Pharma USA Inc.
$98
Flexion Therapeutics, Inc.
$97
Mallinckrodt LLC
$97
Johnson & Johnson Health Care Systems Inc.
$93
Stryker Corporation
$90
Aurinia Pharma U.S., Inc.
$83
Sobi, Inc
$64
Pacira Therapeutics, Inc.
$61
Ironwood Pharmaceuticals, Inc
$55
Horizon Pharma plc
$53
Alvogen Inc
$52
Sandoz Inc.
$36
SOBI, INC
$35
Almatica Pharma LLC
$33
West-Ward Pharmaceuticals
$33
Organon Llc
$31
FIDIA PHARMA USA INC.
$30
Biocon Biologics Inc
$24
Mylan Institutional Inc.
$24
Pacira Pharmaceuticals Incorporated
$22
Ultragenyx Pharmaceutical Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Cumberland Pharmaceuticals, Inc.
$19
Nevro Corp.
$19
Teva Pharmaceuticals USA, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Exeltis, USA Inc.
$17
Merck Sharp & Dohme Corporation
$16
MEDEXUS PHARMA, INC.
$15
Top 3 companies account for 41.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUZALLO · EVENITY · EVUSHELD · Enbrel · FASENRA · FORTEO · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Hulio · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · OTREXUP · Ocrevus · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMLANDI · SIMPONI · SIMPONI ARIA · SKYRIZI · STAR · STELARA · Senza · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · Uloric · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $14 per 100 Medicare services performed
Looking for a rheumatology in Naples?
Compare rheumatologys in the Naples area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
9
Per 100K population
2.3
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
3.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alvarez is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (low-engagement, top 15%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alvarez experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Alvarez performed 136,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alvarez receive payments from pharmaceutical companies?
Yes. Dr. Alvarez received a total of $33,039 from 53 companies across 1,184 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alvarez's costs compare to other rheumatologys in Naples?
Dr. Alvarez's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alvarez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →